Haematology Faculty
Full-Time Faculty
Anne Mwirigi,
BSc, MBChB, MRCP, FRCPath
Dr. Mwirigi graduated with a MBChB degree from the University of Glasgow in 2002, having also a pursued an intercalated degree earning her Bsc (MedSci) in 2000 from the same university. After 4 years of Internal Medicine training in Glasgow and gaining Membership of the Royal College of Physicians in 2007, she commenced her career in Hematology as a Senior House Officer at King’s College Hospital. She thereafter became a Specialist Registrar at Guy’s and St Thomas’ NHS Trust in 2009 and a Fellow of the Royal College of Pathologist in Hematology in 2012. She obtained her Certificate of Completion of Training (CCT) in 2014, and later took up consultant position for a period of two and a half years at both Guy’s and St Thomas’ and King’s College Hospitals. Dr. Mwirigi was recently a sub-investigator in the MEDALIST 2016 trial looking at the efficacy of luspatercept, a novel drug, in patients with myelodysplastic syndrome with ring sideroblasts who require blood transfusions. Dr. Mwirigi is an active member of various local and international hematological societies
Publications
-
Gardner K, Douiri A, Drasar E, Allman M, Mwirigi A et al. Survival in adults with sickle cell disease in a high-income setting. Blood 2016; 128(10):1436-8 DOI 10.1182/blood-2016-05-716910.
Mwirigi A., Hunt BJ. Re: Length of stay after Hip Fracture and short-term risk of death after discharge: a total cohort study in Sweden. BMJ 2015; 350:h696.
Mwirigi, A et al. Is there benefit in extensive screening for cancer in patients with unprovoked venous thromboembolism? Thromb. Res. Dec 2015; 136(6); 1332-1333.
